Suppr超能文献

与健康的HLA - B27阳性受试者相比,强直性脊柱炎患者的HLA - B27表达水平升高:这可能是疾病发展的另一个易感性因素。

Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.

作者信息

Cauli A, Dessole G, Fiorillo M T, Vacca A, Mameli A, Bitti P, Passiu G, Sorrentino R, Mathieu A

机构信息

Cattedra di Reumatologia II, University of Cagliari, Sardinia, Italy.

出版信息

Rheumatology (Oxford). 2002 Dec;41(12):1375-9. doi: 10.1093/rheumatology/41.12.1375.

Abstract

OBJECTIVE

In B27 transgenic rats, susceptibility to the development of a spondyloarthropathy-like disease has been shown to correlate with the level of B27 transgene expression on lymphoid cells. The aim of this work was to study HLA-B27 molecule expression in peripheral blood mononuclear cells (PBMCs) from patients with ankylosing spondylitis (AS) and from normal controls (NC).

METHODS

Twenty B27(+) AS patients and 16 B27(+) NC were studied. HLA-B27 whole molecules and free heavy chains (HCs) and total HLA class I molecules were evaluated at the surface of PBMCs by immunofluorescence and flow cytometry. B27 subtypes were defined with the PCR-SSP (polymerase chain reaction-sequence-specific primer) technique. Cellular activation was evaluated by the expression of CD69, CD25 molecules and interferon gamma (IFN-gamma) production.

RESULTS

B27 expression was 55,536.3+/-18,961.0 MESF (molecules of equivalent soluble fluorochromes) units in AS and 25,936.0+/-12,117.5 MESF in NC (P=0.00009), total HLA class I expression was 448,840.2+/-136,293.8 MESF in AS and 533,494.4+/-232,931.1 MESF in NC (not significant), HC expression was 10,593.4+/-6,396.1 MESF in AS and 14,843.0+/-7,544.2 MESF in NC (not significant). The higher B27 expression in the SA group was not due to higher cell activation as it was not correlated with CD69 and CD25 expression in PBMCs or with the level of IFN-gamma. HLA-B27 expression did not correlate with indexes of disease status [Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI)].

CONCLUSIONS

We found greater expression of HLA-B27 molecules in patients with AS than in healthy subjects. This phenomenon was not accompanied by general up-regulation of HLA class I molecules or by greater expression of classical T-cell activation markers. On this basis we propose that the higher expression of the HLA-B27 molecules is a further predisposing factor for the development of AS.

摘要

目的

在B27转基因大鼠中,已显示出患脊柱关节病样疾病的易感性与淋巴样细胞上B27转基因表达水平相关。本研究的目的是研究强直性脊柱炎(AS)患者和正常对照(NC)外周血单个核细胞(PBMC)中HLA - B27分子的表达。

方法

研究了20例B27阳性的AS患者和16例B27阳性的NC。通过免疫荧光和流式细胞术评估PBMC表面的HLA - B27全分子、游离重链(HC)和总HLA I类分子。用PCR - SSP(聚合酶链反应 - 序列特异性引物)技术确定B27亚型。通过CD69、CD25分子的表达和干扰素γ(IFN - γ)的产生评估细胞活化。

结果

AS组中B27表达为55,536.3±18,961.0 MESF(等效可溶性荧光染料分子)单位,NC组为25,936.0±12,117.5 MESF(P = 0.00009);AS组中总HLA I类分子表达为448,840.2±136,293.8 MESF,NC组为533,494.4±232,931.1 MESF(无显著性差异);AS组中HC表达为10,593.4±6,396.1 MESF,NC组为14,843.0±7,544.2 MESF(无显著性差异)。AS组中较高的B27表达并非由于细胞活化增加,因为它与PBMC中的CD69和CD25表达或IFN - γ水平无关。HLA - B27表达与疾病状态指标[巴斯强直性脊柱炎疾病活动指数(BASDAI)、巴斯强直性脊柱炎功能指数(BASFI)和巴斯强直性脊柱炎计量指数(BASMI)]无关。

结论

我们发现AS患者中HLA - B27分子的表达高于健康受试者。这种现象并未伴随着HLA I类分子的普遍上调或经典T细胞活化标志物的更高表达。在此基础上,我们提出HLA - B27分子的较高表达是AS发病的另一个易感因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验